DOI : 10.1055/s-00000034

Klinische Pädiatrie

Issue 02 · Volume 226 · March 2014 DOI: 10.1055/s-004-26695


2nd International Symposium on Childhood, Adolescent and Young Adult Hodgkin Lymphoma
Langenbeck-Virchow-Haus, Berlin, Germany, 7. – 10. May 2014

Chairs: apl. Prof. Dr. Christine Mauz-Körholz, Halle (Saale), Germany, Dr. Monika Metzger, Memphis, TN, USA
Abstracts (HTML) List of Authors
O_07
Plattel, WJ; van den Berg, A; Alsada, Z; Diepstra, A; van Imhoff, G; Visser, L: Comparison of Serial Plasma Galectin-1, sCD163 and sCD30 with Plasma TARC Levels as Circulating Biomarkers for Response Evaluation in Classical Hodgkin Lymphoma
O_08
Hoppe, B; Hoppe, R: Variable Interpretations of Involved-Site Radiation Therapy Guidelines by Experienced Radiation Oncologists
O_09
Keller, F; Castellino, S; Constine, L; Voss, S; Thomson, J; Dunphy, C; McCarten, K; Chen, L; Schwartz, C: Intensive Therapy Free Survival (ITFS) for Early-Stage Hodgkin Lymphoma (cHL) Including Chemotherapy and Radiation Therapy (IFRT) for Recurrence after Chemotherapy alone
O_10
Appel, B; Chen, L; Hutchison, R; Hodgson, D; Ehrlich, P; Constine, L; Schwartz, C: Treatment of Pediatric Lymphocyte Predominant Hodgkin Lymphoma (LPHL): A Report from the Children's Oncology Group
P_15
Schiavon, JL; Cristofano, C; Lederman, HM: The Use of DWI WB-MRI in Pediatric Oncology, a Single Institution Experience and Pictorial Essay
P_16
Mascarin, M; Elia, C; Bianchi, M; Bertolini, P; Buffardi, S; Caniglia, M; Caruso, R; Cellini, M; Cesaro, S; Consarino, C; D'Amico, S; De Santis, R; Farruggia, P; Cecinati, V; Garaventa, A; Indolfi, P; Moleti, ML; Murgia, G; Nardi, M; Pierani, P; Porta, F; Rondelli, R; Sala, A; Santoro, N; Todesco, A; Zanazzo, GA; Zecca, M; Burnelli, R: Lymphocyte Predominant Hodgkin Lymphoma. A Multicenter Retrospective 30-Year Experience of the Italian Pediatric Hematology and Oncology Association (AIEOP)
P_17
Staege, MS; Volkmer, I; Kewitz, S; Körholz, D: Hodgkin's Lymphoma Specific Transcripts and Minimal Residual Disease Detection
P_18
Ewalt, M; Metcalf, R; Castellanos, M; Zhao, S; Natkunam, Y; Luna-Feinman, S: Classical Hodgkin Lymphoma in Guatemalan Children of Age Less than Six Show High pPrevalence of EBV, HGAL and CD137: Prognostic and Therapeutic Implications
P_19
Hoppe, B; Holtzman, A; Li, Z; Su, Z; Slayton, W; Ozdemir, S; Joyce, M; Sandler, E; Mendenhall, N; Flampouri, S: Advancing the Therapeutic Index of Pediatric Patients with Stage III and IV Hodgkin Lymphoma with Proton Therapy
P_20
Mauz-Körholz, C; Hasenclever, D; Holzendorf, V; Jürgens, H; Burdach, S; Eggert, A; Berthold, F; Müller, H; Frühwald, M; Klingebiel, T; Metzler, M; Körholz, D: Feasibility of VECOPA a Dose-Intensive Regimen for Pediatric Intermediate and Advanced Stage Hodgkin's Lymphoma: Results of the GPOH-HD-2002/VECOPA-Pilot Study
P_21
Naz, F; Muhammad, S: Hodgkin Disease in Pakistani Children: Outcome with Treatment Primarily Based on Chemotherapy with ABVD/COPDAC and Radiotherapy for Residual Disease